ABBVIE
Expansion of medical devices facility in Ireland
Biopharmaceutical company Abbvie (North Chicago, Illinois / USA; www.abbvie.com) is investing EUR 40m in an expansion of its medical devices manufacturing plant in Ballytivnan, Sligo / Ireland. The expansion is expected to take place over the next four years, creating 50 new jobs.

Including the new investment, Abbvie said it will have invested more than EUR 134m in the Ballytivnan site and other manufacturing operations in Ireland since 2013, when the group was launched as an independent biopharmaceutical company. Abbvie has 13 manufacturing sites across the USA, Europe, Asia and Puerto Rico, of which three are in Ireland – two in Sligo and one in Cork.

The Ballytivnan site has facilities for precision engineering, plastics moulding and metrology (the theoretical and practical aspects of measurement). It currently produces drug delivery devices, including a pen-style injector used to treat auto-immune conditions.
09.07.2015 Plasteurope.com [231582-0]
Published on 09.07.2015

© 2001-2024 Plasteurope.com  |  Imprint  |  Privacy  |  Cookie settings

Plasteurope.com is a business information platform for the European plastics industry. It is part of KI Kunststoff Information and PIE Plastics Information Europe, one of the leading content providers for the European plastics industry. We offer daily updated business news and reports, in-depth market analysis, polymer prices and other services for the international plastics industry, including a suppliers guide, career opportunities, a trade name directory and videos.

News | Polymer Prices | Material Databases | Plastics Exchange | Suppliers Guide | Jobs | Register | Advertising

PIE – Plastics Information Europe | KI – Kunststoff Information | KunststoffWeb | Plastics Material Exchange | Polyglobe | K-Profi
© 2001-2024 by Plasteurope.com, Bad Homburg
Date of print: 25.12.2024 05:23:04   (Ref: 464101866)
Text and images are subject to copyright and other laws for protection of intellectual property.
Any duplication or distribution in any media as a whole or in parts requires prior written approval by Plasteurope. URL: http://www.plasteurope.com/news/detail.asp